Search results
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial...
Benzinga· 6 days agoMediPharm Labs Corp. LABS MEDIF MLZ announced its financial results for the first quarter ended...
An experimental weight loss drug helped users lose 18% of their weight in an early trial
Quartz· 5 days agoSwiss pharma giant Roche posted positive results on Thursday of its phase-1 clinical trail for its...
...each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the...
WKRN Nashville· 6 days agoThe Tender Offer is scheduled to expire at 5:00 p.m., Eastern Standard...
FTSE 100 Live 21 May: Index falls away from record highs, AstraZeneca leads risers after new revenue...
Evening Standard via Yahoo Finance· 1 hour agoLondon’s status as a financial capital is under attack, but from the Far and Middle East, not from...
Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
Digital Journal· 6 days agoProfessor Jan Lundberg has more than 25 years of experience from leading positions in global pharmaceutical companies, including as global head of research ...
Pharma industry manufacturer Particle Dynamics names new CFO - St. Louis Business Journal
The Business Journals· 4 days agoParticle Dynamics, a provider of products and technologies for the pharmaceutical industry, has...
London stocks fall as Fed's cautious stance weighs on sentiment
Reuters via Yahoo News· 4 hours ago(Reuters) -London stocks slipped on Tuesday, tracking weakness in Asian markets as U.S. Federal...
Earnings call: Lonza maintains outlook despite Q1 performance lag By Investing.com
Investing.com· 7 days agoLonza Group AG (LONN.SW), a global leader in life sciences, reported a softer performance in the...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 17 hours agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Communiqué from the Annual General Meeting of AlzeCure Pharma on 14 May 2024
Digital Journal· 7 days agoThe annual general meeting resolved to adopt the profit and loss statement and the balance sheet. The annual general meeting also resolved to allocate the Company's result in accordance with ...